The KNSTRN Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the widely used HEK293T human embryonic kidney cell line. This product provides a heterogeneous pool of cells carrying targeted disruption of the KNSTRN gene, enabling loss-of-function studies without selection for a single clonal isolate. The polyclonal nature of the knockout pool preserves cellular diversity and avoids clonal artifacts, making it suitable for experiments where population-level phenotypes such as mitotic index, chromosome segregation fidelity, and cell cycle distribution are assessed. Researchers can exploit this knockout model to interrogate kinetochore biology and mitotic checkpoint signaling in an isogenic background with high experimental throughput.
HEK293T cells are a robust host platform originally derived from human embryonic kidney cells transformed with adenovirus 5 DNA and constitutively expressing the SV40 large T antigen. These features endow HEK293T with exceptional transfection efficiency, rapid proliferation, and high capacity for recombinant protein expression and virus production. The line is a staple in both basic cell biology and applied biotechnology, frequently serving as a model for studying signaling transduction, protein?Cprotein interactions, and cell cycle regulation. Its ease of culture and well?characterized behavior under standard conditions make it an ideal chassis for generating defined genetic knockouts, as it can be efficiently edited using CRISPR/Cas9 technology and subjected to a range of downstream biochemical and imaging analyses.
KNSTRN (kinetochore?localized astrin/SPAG5?binding protein) operates as a key component of the astrin?CSKAP complex at kinetochores, where it stabilizes microtubule?Ckinetochore attachments and facilitates the generation of intra?kinetochore tension. The protein is phosphorylated by Aurora B kinase and functions downstream of CDK1?driven mitotic entry, with transcription regulated in part by E2F1. Within the kinetochore network, KNSTRN interacts directly with SPAG5 (astrin), CLASP1, and the NDC80 complex, integrating signals that govern spindle assembly checkpoint silencing. By interacting with CLASP1 and NDC80, KNSTRN participates in the precise modulation of microtubule plus?end dynamics at attachment sites, thereby promoting proper chromosome alignment at the metaphase plate. Disruption of KNSTRN leads to persistent checkpoint activation, which is mediated through downstream effectors such as BUB1B (BubR1) and MAD2L1 (Mad2), and ultimately to mitotic delay and chromosome missegregation.
In the HEK293T background, ablation of KNSTRN creates a physiologically relevant cellular model for studying the molecular consequences of impaired kinetochore?Cmicrotubule attachment stability. The high transfection efficiency of the host cells permits complementation with exogenous KNSTRN constructs, mutant variants, or fluorescent fusion proteins, facilitating structure?Cfunction analyses. Moreover, the fast doubling time and adaptability to high?content imaging platforms render this knockout population especially useful for live?cell imaging of mitotic progression and for screening libraries of small molecules that target the mitotic apparatus. The combination of a well?defined human embryonic kidney cell background and targeted gene disruption enables researchers to dissect KNSTRN?dependent functions without the confounding effects of immortalization?associated genomic instability typical of some cancer cell lines.
This knockout model supports a broad spectrum of experimental applications in mitosis research, chromosome instability studies, and cancer cell biology. Typical assays include Western blotting for KNSTRN and phospho?Aurora B, immunofluorescence staining of kinetochore proteins and microtubules, flow cytometry for cell cycle profiling, and time?lapse microscopy to monitor mitotic timing and chromosome alignment. Co?immunoprecipitation can be used to assess interactions with SPAG5 and CLASP1, while phospho?kinase assays evaluate Aurora B and CDK1 activity. The cells are also suited for siRNA complementation studies and for testing anti?mitotic drug candidates that target the spindle assembly checkpoint. For further information, please contact Ascent Research.
